SYNB Putnam Biorevolution ETF

93

NYSE ARCA | ETF

Price
$29.8324
Increased by +0.92%
Dollar Volume (20D)
N/A
ADR%
3.42

Top 12 Holdings

Asset Name Sector Industry Weight
NVDA NVIDIA Corporation Technology Semiconductors 7.66%
TMO Thermo Fisher Scientific Inc Healthcare Diagnostics & Research 7.3%
DHR Danaher Corporation Healthcare Diagnostics & Research 6.69%
BIO Bio-Rad Laboratories Inc Healthcare Medical Devices 5.56%
GOOGL Alphabet Inc Class A Communication Services Internet Content & Information 5.47%
CTVA Corteva Inc Basic Materials Agricultural Inputs 4.6%
NVZMY Novozymes AS Basic Materials Specialty Chemicals 4.49%
ABBV AbbVie Inc Healthcare Drug Manufacturers - General 4.24%
ASND Ascendis Pharma AS Healthcare Biotechnology 3.93%
LLY Eli Lilly and Company Healthcare Drug Manufacturers - General 3.57%
DD Dupont De Nemours Inc Basic Materials Specialty Chemicals 3.46%
LULU Lululemon Athletica Inc. Consumer Cyclical Apparel Retail 3.41%
Open dropdown content
Open dropdown content
DAILY
WEEKLY
MONTHLY

The fund invests mainly in common stocks (growth or value stocks or both) of companies worldwide of any size with a focus on "biology revolution" companies. From time to time, the fund may invest a significant portion of its assets in companies in one or more related industries or sectors, including the health care, consumer discretionary, consumer staples, biotechnology and materials sectors. The fund is non-diversified.